Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy

Background: To determine KRAS gene in circulating tumor DNA in comparison with histological grading through liquid biopsy in colorectal cancer patients. Methods: This dual-centered cross-sectional study included 73 diagnosed patients of colorectal cancer at different grading levels [Grade I, well di...

Full description

Bibliographic Details
Main Authors: Hafiz Syed Mohammad Osama Jafri, Shamim Mushtaq, Saeeda Baig, Afreen Bhatty, Sabra Siraj
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2023;volume=29;issue=6;spage=371;epage=375;aulast=Jafri
_version_ 1797226218289889280
author Hafiz Syed Mohammad Osama Jafri
Shamim Mushtaq
Saeeda Baig
Afreen Bhatty
Sabra Siraj
author_facet Hafiz Syed Mohammad Osama Jafri
Shamim Mushtaq
Saeeda Baig
Afreen Bhatty
Sabra Siraj
author_sort Hafiz Syed Mohammad Osama Jafri
collection DOAJ
description Background: To determine KRAS gene in circulating tumor DNA in comparison with histological grading through liquid biopsy in colorectal cancer patients. Methods: This dual-centered cross-sectional study included 73 diagnosed patients of colorectal cancer at different grading levels [Grade I, well differentiated (n = 7, 9.5%); Grade II, moderately differentiated (n = 14,18.9%); and Grade III, poorly differentiated (n = 52, 70%)]. Blood was collected, and plasma was separated. ctDNA was extracted, using magnetic bead-based technique (MagMAX Cell-Free DNA kit). KRAS gene was quantified through qPCR. STRING database was used to find KRAS interactomes. Results: Mean threshold cycle (CT value) of KRAS gene in Grade III samples showed significantly higher (P = 0.001) levels of ctDNA (2.7 ± 1.14) compared with Grade II and Grade I (3.1 ± 0.68, 2.3 ± 0.60), respectively. Grading characterization showed that rectal cancer (n = 22, 42.3%) with Grade III (68.8%) was more prevalent than colon and sigmoid cancer (n = 19, 36.5%, n = 11, 21%, respectively). STRING database showed 10 functional genes interacting with KRAS expressed as gene/proteins. Conclusion: Liquid biopsy can be used to detect ctDNA in plasma of CRC patients and enabled to detect the KRAS gene by qPCR. The technique being less invasive and cost-effective is convenient for multiple biopsies in different cancers.
first_indexed 2024-04-24T14:21:25Z
format Article
id doaj.art-53a47df9807341cba3a323417d9a4760
institution Directory Open Access Journal
issn 1319-3767
1998-4049
language English
last_indexed 2024-04-24T14:21:25Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series The Saudi Journal of Gastroenterology
spelling doaj.art-53a47df9807341cba3a323417d9a47602024-04-03T06:40:25ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492023-01-0129637137510.4103/sjg.sjg_85_23Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsyHafiz Syed Mohammad Osama JafriShamim MushtaqSaeeda BaigAfreen BhattySabra SirajBackground: To determine KRAS gene in circulating tumor DNA in comparison with histological grading through liquid biopsy in colorectal cancer patients. Methods: This dual-centered cross-sectional study included 73 diagnosed patients of colorectal cancer at different grading levels [Grade I, well differentiated (n = 7, 9.5%); Grade II, moderately differentiated (n = 14,18.9%); and Grade III, poorly differentiated (n = 52, 70%)]. Blood was collected, and plasma was separated. ctDNA was extracted, using magnetic bead-based technique (MagMAX Cell-Free DNA kit). KRAS gene was quantified through qPCR. STRING database was used to find KRAS interactomes. Results: Mean threshold cycle (CT value) of KRAS gene in Grade III samples showed significantly higher (P = 0.001) levels of ctDNA (2.7 ± 1.14) compared with Grade II and Grade I (3.1 ± 0.68, 2.3 ± 0.60), respectively. Grading characterization showed that rectal cancer (n = 22, 42.3%) with Grade III (68.8%) was more prevalent than colon and sigmoid cancer (n = 19, 36.5%, n = 11, 21%, respectively). STRING database showed 10 functional genes interacting with KRAS expressed as gene/proteins. Conclusion: Liquid biopsy can be used to detect ctDNA in plasma of CRC patients and enabled to detect the KRAS gene by qPCR. The technique being less invasive and cost-effective is convenient for multiple biopsies in different cancers.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2023;volume=29;issue=6;spage=371;epage=375;aulast=Jafricirculating tumor dnacolorectal cancerkrasliquid biopsyqpcr
spellingShingle Hafiz Syed Mohammad Osama Jafri
Shamim Mushtaq
Saeeda Baig
Afreen Bhatty
Sabra Siraj
Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
The Saudi Journal of Gastroenterology
circulating tumor dna
colorectal cancer
kras
liquid biopsy
qpcr
title Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
title_full Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
title_fullStr Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
title_full_unstemmed Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
title_short Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy
title_sort comparison of kras gene in circulating tumor dna levels vs histological grading of colorectal cancer patients through liquid biopsy
topic circulating tumor dna
colorectal cancer
kras
liquid biopsy
qpcr
url http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2023;volume=29;issue=6;spage=371;epage=375;aulast=Jafri
work_keys_str_mv AT hafizsyedmohammadosamajafri comparisonofkrasgeneincirculatingtumordnalevelsvshistologicalgradingofcolorectalcancerpatientsthroughliquidbiopsy
AT shamimmushtaq comparisonofkrasgeneincirculatingtumordnalevelsvshistologicalgradingofcolorectalcancerpatientsthroughliquidbiopsy
AT saeedabaig comparisonofkrasgeneincirculatingtumordnalevelsvshistologicalgradingofcolorectalcancerpatientsthroughliquidbiopsy
AT afreenbhatty comparisonofkrasgeneincirculatingtumordnalevelsvshistologicalgradingofcolorectalcancerpatientsthroughliquidbiopsy
AT sabrasiraj comparisonofkrasgeneincirculatingtumordnalevelsvshistologicalgradingofcolorectalcancerpatientsthroughliquidbiopsy